Phenotype Standardization for Statin-Induced Myotoxicity

Electronic health records for biological sample collection: feasibility study of statin-induced myopathy using the Clinical Practice Research Datalink

(2013) Helen O'Meara et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink

(2013) D F Carr et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Development of a detection algorithm for statin-induced myopathy using electronic medical records

(2013) K. Sai et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies

(2013) Payam Mohassel et al.   MUSCLE & NERVE

Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment

(2013) Louise A. Donnelly et al.   Pharmacogenetics and Genomics

Proportion and Risk Indicators of Nonadherence to Statin Therapy: A Meta-analysis

(2012) Mark Lemstra et al.   CANADIAN JOURNAL OF CARDIOLOGY

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

(2012) R A Wilke et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Drug induced rhabdomyolysis

(2012) Martin Hohenegger   CURRENT OPINION IN PHARMACOLOGY

The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes

(2012) Elijah R. Behr et al.   EUROPEAN HEART JOURNAL

Statin induced myotoxicity

(2012) Sivakumar Sathasivam   European Journal of Internal Medicine

Use of Administrative Data to Estimate the Incidence of Statin-Related Rhabdomyolysis

(2012) Susan R. Heckbert   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting

(2012) Mark J. Cziraky et al.   Journal of Clinical Lipidology

Statin Myopathy: A Lipid Clinic Experience on the Tolerability of Statin Rechallenge

(2011) En C. Fung et al.   Cardiovascular Therapeutics

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

(2011) M Pirmohamed et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Phenotype Standardization Project: Improving Pharmacogenetic Studies of Serious Adverse Drug Reactions

(2011) M Pirmohamed et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Is there clinical benefit to routine enzyme testing of patients on statins?

(2011) Asher Elhayany et al.   Expert Opinion On Drug Safety

Characteristics of Drug-Associated Rhabdomyolysis: Analysis of 8,610 Cases Reported to the U.S. Food and Drug Administration

(2011) Yasuo Oshima   INTERNAL MEDICINE

Managing statin-induced muscle toxicity in a lipid clinic

(2011) O. Blaier et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Cerivastatin, genetic variants, and the risk of rhabdomyolysis

(2011) Kristin D. Marciante et al.   Pharmacogenetics and Genomics

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin

(2011) L R Brunham et al.   PHARMACOGENOMICS JOURNAL

Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects

(2011) Andrew L. Mammen et al.   ARTHRITIS CARE & RESEARCH

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

(2010) Andrew L. Mammen et al.   ARTHRITIS AND RHEUMATISM

Common Nonsynonymous Substitutions in SLCO1B1 Predispose to Statin Intolerance in Routinely Treated Individuals With Type 2 Diabetes: A Go-DARTS Study

(2010) L A Donnelly et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Preempting and preventing drug-induced liver injury

(2010) Guruprasad P Aithal et al.   NATURE GENETICS

Statin-Associated Muscle-Related Adverse Effects: A Case Series of 354 Patients

(2010) Stephanie Cham et al.   PHARMACOTHERAPY

Methods for Causality Assessment of Adverse Drug Reactions

(2009) Taofikat B Agbabiaka et al.   DRUG SAFETY

The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects

(2009) Deepak Voora et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antiretroviral and Statin Drug-Drug Interactions

(2008) Gretchen M. Ray   Cardiology in Review

Unusual causes of rhabdomyolysis

(2008) E. E. Mazokopakis   INTERNAL MEDICINE JOURNAL

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statin Induced Myopathy and Myalgia: Time Trend Analysis and Comparison of Risk Associated with Statin Class from 1991–2006

(2008) Mariam Molokhia et al.   PLoS One